Cyclooxygenase 2 selective inhibitors: Panacea or flash in the pan?
Open Access
- 31 October 1999
- journal article
- editorial
- Published by Elsevier in Gastroenterology
- Vol. 117 (4) , 1002-1005
- https://doi.org/10.1016/s0016-5085(99)70358-6
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- A randomized trial comparing the effect of rofecoxib, a cyclooxygenase 2–specific inhibitor, with that of ibuprofen on the gastroduodenal mucosa of patients with osteoarthritisGastroenterology, 1999
- Effectiveness of lansoprazole in the healing of NSAID-induced gastric ulcer in patients continuing to take NSAIDsGastroenterology, 1998
- Effects of inhibition of prostaglandin endoperoxide synthase‐2 in chronic gastro‐intestinal ulcer models in ratsBritish Journal of Pharmacology, 1998
- Multiple Female Reproductive Failures in Cyclooxygenase 2–Deficient MicePublished by Elsevier ,1997
- Crypt stem cell survival in the mouse intestinal epithelium is regulated by prostaglandins synthesized through cyclooxygenase-1.Journal of Clinical Investigation, 1997
- Exacerbation of inflammation-associated colonic injury in rat through inhibition of cyclooxygenase-2.Journal of Clinical Investigation, 1996
- The macula densa: recent developmentsJournal Of Hypertension, 1996
- THE ROLE OF ANTI-INFLAMMATORY DRUGS IN THE PREVENTION AND TREATMENT OF ALZHEIMER'S DISEASEAnnual Review of Medicine, 1996
- Prostaglandin synthase 1 gene disruption in mice reduces arachidonic acid-induced inflammation and indomethacin-induced gastric ulcerationCell, 1995
- Prostaglandin synthase 2 gene disruption causes severe renal pathology in the mouseCell, 1995